𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cancer-cell traffic in the liver. I. Growth kinetics of cancer cells after portal-vein delivery

✍ Scribed by Emilio Barbera-Guillem; Isabel Smith; Leonard Weiss


Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
604 KB
Volume
52
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Following the intrasplenic injection of B16F10 melanoma cells into mice, at first single cells, and later multicellular tumor foci were observed at different times in the liver. Cell numbers and tumor volumes were determined over the next 12 days, by confocal microscopy of thick liver sections. Fifteen minutes after injection, approximately 20% of the melanoma cells were identified in the liver microvasculature; after 48 hr, only 0.68% of these retained morphologic integrity; by 5 days only 0.13% of the originally detected cells incorporated BUdR; and, by 12 days, these subsequently grew into tumor nodules. Tumor volume changes with time were not exponential and, following a non‐replicative period during the first 2½ days, the volume doubling times increased from approximately 8 to 39 hr at 12 days. BUdR incorporation indicated that this was probably due to a diminishing proliferative fraction in the cancer‐cell population. When animals were killed at 12 days, tumor foci were centered on the liver sinusoids and appeared to represent expansive growth of arrested cells, with no evidence of parenchymal invasion by migrating cancer cells, in spite of the absence of a subendothelial basement membrane. Our direct observations indicate that, in this model system, the post‐delivery phase of hepatic colonization is characterized by high levels of inefficiency with respect to cancer‐cell survival, growth and extravasation. © 1992 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Fate of the human liver after hemihepati
✍ H Harada; H Imamura; S Miyagawa; S Kawasaki 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 886 KB

sence of underlying liver disease was confirmed histologically in cyte volume; HE, hematoxylin and eosin; PVE, portal vein embolization; PCNA, proliferating cell nuclear antigen; TUNEL, terminal deoxyribonucleotidyl transferase-medi-them all. Nine of these patients had no history of cholestasis, ate

Cancer-cell traffic in the liver. II. Ar
✍ Emilio Barbera-Guillem; Isabel Smith; Leonard Weiss 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 572 KB

## Abstract Fluorescent probes were used to detect BUdR‐labelled B16F10 and M5076 cancer cells delivered to the livers of mice via intrasplenic injection. In liver sections stained for succinic dehydrogenase, which permits the periportal, acinar zone I to be distinguished from the pericentral zone

Anti-viral cytotoxic T cells inhibit the
✍ Philip Savage; Pam Cowburn; Aled Clayton; Stephen Man; Tom Lawson; Graham Ogg; N 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB

## Abstract A number of experimental antibody mediated cancer therapies aim to redirect cytotoxic T cells (CTLs) of non‐tumour specificity to cancer cells. It has been previously demonstrated that cancer cells targeted with recombinant HLA‐class I/viral peptide complexes via antibody delivery syste

Flt3 ligand lessens the growth of tumors
✍ Nathalie Favre-Felix; Monique Martin; Eugene Maraskovsky; Annie Fromentin; Moniq 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 630 KB

A defective function of the antigen-presenting cells may represent one of the ways used by cancer cells to escape the immune response. We have previously shown that human and rat colon carcinomas were infiltrated by dendritic cells that did not express the B7 co-stimulatory molecules required for in